These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24510400)

  • 1. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.
    Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Chen VW; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Koyama T; Penson DF
    Cancer; 2014 Apr; 120(8):1263-71. PubMed ID: 24510400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
    Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Koyama T; Albertsen PC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Hoffman RM; Kaplan SH; McCollum D; Paddock LE; Stanford JL; Stroup AM; Wu XC; Penson DF
    Eur Urol; 2015 Jun; 67(6):1019-1025. PubMed ID: 25174325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
    Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Eur Urol; 2020 Aug; 78(2):248-255. PubMed ID: 32098731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.
    Donnelly DW; Gavin A; Downing A; Hounsome L; Kearney T; McNair E; Allan D; Huws DW; Wright P; Selby PJ; Kind P; Watson E; Wagland R; Wilding S; Butcher H; Mottram R; Allen M; McSorley O; Sharp L; Mason MD; Cross WR; Catto JWF; Glaser AW
    Eur Urol; 2019 Aug; 76(2):228-237. PubMed ID: 31060822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
    Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
    Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
    Tyson MD; Koyama T; Lee D; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen V; Conwill R; McCollum D; Penson DF; Barocas DA
    Eur Urol; 2018 Jul; 74(1):26-33. PubMed ID: 29501451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study.
    Vernooij RWM; Cremers RGHM; Jansen H; Somford DM; Kiemeney LA; van Andel G; Wijsman BP; Busstra MB; van Moorselaar RJA; Wijnen EM; Pos FJ; Hulshof MCCM; Hamberg P; van den Berkmortel F; Hulsbergen-van de Kaa CA; van Leenders GJLH; Fütterer JJ; van Oort IM; Aben KKH
    Urol Oncol; 2020 Sep; 38(9):735.e17-735.e25. PubMed ID: 32680820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary, bowel and sexual health in older men from Northern Ireland.
    Donnelly DW; Donnelly C; Kearney T; Weller D; Sharp L; Downing A; Wilding S; Wright P; Kind P; Catto JWF; Cross WR; Mason MD; McCaughan E; Wagland R; Watson E; Mottram R; Allen M; Butcher H; Hounsome L; Selby P; Huws D; Brewster DH; McNair E; Rivas C; Nayoan J; Horton M; Matheson L; Glaser AW; Gavin A
    BJU Int; 2018 Nov; 122(5):845-857. PubMed ID: 29489050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
    Stanford JL; Feng Z; Hamilton AS; Gilliland FD; Stephenson RA; Eley JW; Albertsen PC; Harlan LC; Potosky AL
    JAMA; 2000 Jan; 283(3):354-60. PubMed ID: 10647798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.
    Talcott JA; Rieker P; Clark JA; Propert KJ; Weeks JC; Beard CJ; Wishnow KI; Kaplan I; Loughlin KR; Richie JP; Kantoff PW
    J Clin Oncol; 1998 Jan; 16(1):275-83. PubMed ID: 9440753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
    Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
    BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study.
    Avulova S; Zhao Z; Lee D; Huang LC; Koyama T; Hoffman KE; Conwill RM; Wu XC; Chen V; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Resnick MJ; Penson DF; Barocas DA
    J Urol; 2018 May; 199(5):1202-1209. PubMed ID: 29253578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term functional outcomes after treatment for localized prostate cancer.
    Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
    N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
    Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
    Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer.
    Lee DJ; Barocas DA; Zhao Z; Huang LC; Resnick MJ; Koyoma T; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):116-126. PubMed ID: 30102188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.
    Korfage IJ; Roobol M; de Koning HJ; Kirkels WJ; Schröder FH; Essink-Bot ML
    Urology; 2008 Jul; 72(1):3-9. PubMed ID: 18384849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.
    Hoppe BS; Nichols RC; Henderson RH; Morris CG; Williams CR; Costa J; Marcus RB; Mendenhall WM; Li Z; Mendenhall NP
    Cancer; 2012 Sep; 118(18):4619-26. PubMed ID: 22253020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.
    Wallis CJD; Huang LC; Zhao Z; Penson DF; Koyama T; Conwill R; Tallman JE; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Barocas DA; Hoffman KE
    Urol Oncol; 2022 Feb; 40(2):56.e1-56.e8. PubMed ID: 34154899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.